Attached files

file filename
EX-5.1 - EX-5.1 - NEVRO CORPa14-14480_11ex5d1.htm
EX-23.1 - EX-23.1 - NEVRO CORPa14-14480_11ex23d1.htm

As filed with the Securities and Exchange Commission on November 5, 2014

Registration No. 333-       

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM S-1

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 


 

NEVRO CORP.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

3841

 

56-2568057

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

4040 Campbell Avenue
Menlo Park, CA 94025
(650) 251-0005
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

 


 

Michael DeMane
Chief Executive Officer
Nevro Corp.
4040 Campbell Avenue
Menlo Park, CA 94025
(650) 251-0005
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)

 


 

Copies to:

 

Michael W. Hall, Esq.

Anthony J. Richmond, Esq.

Brian J. Cuneo, Esq.

Latham & Watkins LLP

140 Scott Drive

Menlo Park, CA 94025

Telephone: (650) 328-4600

Facsimile: (650) 463-2600

 

Andrew H. Galligan

Vice President of Finance,

Chief Financial Officer

Nevro Corp.

4040 Campbell Avenue

Menlo Park, CA 94025

Telephone: (650) 251-0005

Facsimile: (650) 251-9415

 

Alan F. Denenberg, Esq.

Davis Polk & Wardwell LLP

1600 El Camino Real

Menlo Park, CA 94025

Telephone: (650) 752-2000

Facsimile: (650) 752-2111

 

Approximate date of commencement of proposed sale to the public:
As soon as practicable after this Registration Statement becomes effective.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.  o

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  x  333-199156

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  o

 

Accelerated filer  o

 

Non-accelerated filer  x
(Do not check if a smaller reporting company)

 

Smaller reporting company  o

 

CALCULATION OF REGISTRATION FEE

 

Title of each class of
securities to be registered

 

Amount to be
registered (1)

 

Proposed maximum
offering price per
share

 

Proposed maximum
aggregate
offering price

 

Amount of
registration fee(2)

 

Common Stock, $0.001 par value per share

 

862,500 shar

es

$

18.00

 

$

15,525,000

 

$

1,805

 

 

(1)          Represents only the additional number of shares being registered and includes 112,500 additional shares that the underwriters have the option to purchase.  In accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended, the amount being registered does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1 (File No. 333-199156).

 

(2)          The registration fee is calculated in accordance with Rule 457(a) under the Securities Act of 1933, as amended, based on the proposed maximum aggregate offering price. The Registrant previously registered securities at an aggregate offering price not to exceed $122,187,500 on a Registration Statement on Form S-1 (File No. 333-199156), which was declared effective by the Securities and Exchange Commission on November 5, 2014. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of $15,525,000 is hereby registered.

 


 

This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) under the Securities Act of 1933, as amended.

 

 

 



 

EXPLANATORY NOTE AND INCORPORATION BY REFERENCE

 

This registration statement is being filed with respect to the registration of additional shares of common stock, par value $0.001 per share, of Nevro Corp., a Delaware corporation, pursuant to Rule 462(b) promulgated under the Securities Act of 1933, as amended. The contents of the earlier registration statement on Form S-1, as amended (File No. 333-199156) (the “Original Registration Statement”), which was declared effective by the Securities and Exchange Commission on November 5, 2014, are incorporated in this registration statement by reference. This registration statement is being filed solely to increase the amount of securities offered pursuant to the Original Registration Statement.

 

The required opinion and consents are listed on an Exhibit Index attached hereto and filed herewith.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in Menlo Park, California, on November 5, 2014.

 

 

Nevro Corp.

 

 

 

By:

/s/ Michael DeMane

 

 

Michael DeMane

 

 

Chief Executive Officer

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Michael DeMane

 

Chief Executive Officer and Chairman of the Board (Principal Executive Officer)

 

November 5, 2014

Michael DeMane

 

 

 

 

 

 

 

 

/s/ Andrew H. Galligan

 

Vice President of Finance and Chief Financial Officer (Principal Financial and Accounting Officer)

 

November 5, 2014

Andrew H. Galligan

 

 

 

 

 

 

 

 

*

 

Director

 

November 5, 2014

Ali Behbahani, M.D.

 

 

 

 

 

 

 

 

 

*

 

Director

 

November 5, 2014

Peter T. Bisgaard

 

 

 

 

 

 

 

 

 

*

 

Director

 

November 5, 2014

Frank Fischer

 

 

 

 

 

 

 

 

 

*

 

Director

 

November 5, 2014

Wilfred E. Jaeger, M.D.

 

 

 

 

 

 

 

 

 

*

 

Director

 

November 5, 2014

Shawn T McCormick

 

 

 

 

 

 

 

 

 

*

 

Director

 

November 5, 2014

Nathan B. Pliam, M.D.

 

 

 

 

 

*By:

/s/ Andrew H. Galligan

 

 

Andrew H. Galligan

 

 

Attorney-in-fact

 

 

4



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

1.1(1)

 

Form of Underwriting Agreement

 

 

 

5.1

 

Opinion of Latham & Watkins LLP

 

 

 

23.1

 

Consent of independent registered public accounting firm.

 

 

 

23.2

 

Consent of Latham & Watkins LLP (included in Exhibit 5.1).

 

 

 

24.1(2)

 

Powers of Attorney

 


(1)                   Previously filed as Exhibit 1.1 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-199156), originally filed with the Securities and Exchange Commission on October 3, 2014 and incorporated by reference herein.

 

(2)                   Previously filed on the signature page to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-199156), originally filed with the Securities and Exchange Commission on October 3, 2014 and incorporated by reference herein.

 

5